G. Alves‐Filho

Posttransplant diabetes mellitus: incidence and risk factors.

M. Mazzali, C. Lalli, G. Alves-Filho, 2008, Transplantation proceedings.

12‐month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients

J. Pascual, H. Tedesco-Silva, P. Rigotti, 2007, Transplant international : official journal of the European Society for Organ Transplantation.

Chronic liver disease in kidney recipients with hepatitis C virus infection

L. Meirelles, E. Soares, N. Nishimura, 2003, Clinical transplantation.

Systemic lupus erythematosus after renal transplantation: is complement a good marker for graft survival?

M. Mazzali, A. L. Signori Baracat, M. A. Ribeiro-Alves, 2008, Transplantation proceedings.

Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis.

E. Bronzatto, M. Mazzali, G. Alves-Filho, 2009, Transplantation proceedings.

Posttransplant diabetes mellitus: incidence and risk factors.

M. Mazzali, C. Lalli, G. Alves‐Filho, 2008, Transplantation proceedings.

Acute tubulointerstitial nephritis and uveitis with antineutrophil cytoplasmic antibody.

M. A. Ribeiro-Alves, G. Alves-Filho, A. Simon, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Nonrecurrent hemolytic uremic syndrome (HUS de novo) as cause of acute renal failure after renal transplant.

M. Mazzali, M. A. Ribeiro-Alves, G. Alves-Filho, 1997, Renal failure.

Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients.

C. A. de Souza, M. Mazzali, S. Marques, 2007, Transplantation proceedings.